Tesaro Secures $20,000,000 Series A Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e8e265b-caa4-45a8-969c-484b40c9c974&Preview=1
Date
5/26/2010
Company Name
Tesaro
Mailing Address
135 Clarendon St. Boston, MA 02116
Company Description
TESARO is a privately held oncology-focused biopharmaceutical company whose passionate associates are dedicated to improving the lives of cancer patients by developing and providing safer and more effective therapeutics and supportive care products.
Website
http://www.tesarobio.com
Transaction Type
Venture Equity
Transaction Amount
$20,000,000
Transaction Round
Series A
Proceeds Purposes
The company will use the funding to acquire, develop and commercialize cancer therapeutics and supportive care products.
M&A Terms
Venture Investor
New Enterprise Associates
Venture Investor
New Enterprise Associates
Venture Investor
Undisclosed